Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Amazon
AMZN
|
$1.55B |
| 2 |
Meta Platforms (Facebook)
META
|
$795M |
| 3 |
MongoDB
MDB
|
$604M |
| 4 |
HubSpot
HUBS
|
$343M |
| 5 |
Arm
ARM
|
$340M |
Top Sells
| 1 |
Apple
AAPL
|
$1.86B |
| 2 |
NVIDIA
NVDA
|
$964M |
| 3 |
UnitedHealth
UNH
|
$599M |
| 4 |
S&P Global
SPGI
|
$560M |
| 5 |
American Express
AXP
|
$287M |
Sector Composition
| 1 | Technology | 36.88% |
| 2 | Consumer Discretionary | 20.92% |
| 3 | Healthcare | 13.78% |
| 4 | Communication Services | 9.74% |
| 5 | Financials | 8.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Golden Entertainment
GDEN
$649M
| $13.3M | 0.01% |
389,455
+98,186
| +34% | +$3.36M |
|
352
Chart Industries
GTLS
$8.96B
| $13.2M | 0.01% |
78,299
+9,199
| +13% | +$1.56M |
|
353
BCE
BCE
$23.1B
| $12.8M | 0.01% |
333,723
-6,736
| -2% | -$257K |
|
|
AXNX
354
DELISTED
Axonics, Inc. Common Stock
AXNX
| $12.7M | 0.01% |
225,957
+24,631
| +12% | +$1.38M |
|
355
Transocean
RIG
$2.9B
| $12.6M | 0.01% |
1,530,659
+331,953
| +28% | +$2.73M |
|
356
DT Midstream
DTM
$10.7B
| $12.2M | 0.01% |
231,289
+4,339
| +2% | +$230K |
|
357
Expro
XPRO
$1.43B
| $12.2M | 0.01% |
524,373
+61,121
| +13% | +$1.42M |
|
358
Immunovant
IMVT
$2.99B
| $12M | 0.01% |
+313,191
| New | +$12M |
|
359
Coupang
CPNG
$52.7B
| $11.9M | 0.01% |
698,523
-77,328
| -10% | -$1.31M |
|
360
Enterprise Financial Services Corp
EFSC
$2.24B
| $11.5M | 0.01% |
306,252
-213,097
| -41% | -$7.99M |
|
|
RVNC
361
DELISTED
Revance Therapeutics, Inc.
RVNC
| $11.4M | 0.01% |
997,616
-841,651
| -46% | -$9.65M |
|
362
Antero Midstream
AM
$8.73B
| $11.3M | 0.01% |
+946,425
| New | +$11.3M |
|
363
New Fortress Energy
NFE
$672M
| $11.2M | 0.01% |
341,210
+13,895
| +4% | +$455K |
|
|
TXNM
364
TXNM Energy, Inc.
TXNM
$5.99B
| $11.2M | 0.01% |
250,306
-8,153
| -3% | -$364K |
|
|
ATVI
365
DELISTED
Activision Blizzard Inc.
ATVI
| $11.1M | 0.01% |
118,418
-81,101
| -41% | -$7.59M |
|
366
Corteva
CTVA
$49.1B
| $10.9M | 0.01% |
212,796
+1,840
| +0.9% | +$94.1K |
|
|
ITCI
367
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $9.73M | 0.01% |
186,867
+24,094
| +15% | +$1.26M |
|
368
MaxLinear
MXL
$1.36B
| $9.58M | 0.01% |
430,689
-640,303
| -60% | -$14.2M |
|
369
Entegris
ENTG
$12.4B
| $9.53M | 0.01% |
+101,457
| New | +$9.53M |
|
370
AT&T
T
$212B
| $9.45M | 0.01% |
628,930
-188,337
| -23% | -$2.83M |
|
371
Veracyte
VCYT
$2.55B
| $9.32M | 0.01% |
+417,552
| New | +$9.32M |
|
|
AAMI
372
Acadian Asset Management Inc.
AAMI
$1.59B
| $9.26M | 0.01% |
477,425
+4,100
| +0.9% | +$79.5K |
|
373
Alibaba
BABA
$323B
| $9.18M | 0.01% |
105,811
-11,548
| -10% | -$1M |
|
374
iShares Russell 1000 Growth ETF
IWF
$117B
| $9M | 0.01% |
33,836
+10,118
| +43% | +$2.69M |
|
375
Canadian National Railway
CNI
$60.3B
| $8.93M | 0.01% |
82,431
-19,009
| -19% | -$2.06M |
|